Description and analysis of the VA National Formulary
| Corporate Authors: | , |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | Inglés |
| Published: |
Washington, D.C. :
National Academy Press
c2000.
|
| Edition: | 1st ed |
| Subjects: | |
| See on Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820326806719 |
Table of Contents:
- DESCRIPTION AND ANALYSIS OF THE VA National Formulary
- Copyright
- Preface
- REVIEWERS
- Contents
- Executive Summary
- SUMMARY AND CONCLUSIONS
- Restrictiveness
- Cost
- Quality
- Comparisons
- Recommendations
- 1 Introduction
- LEGISLATIVE AND EXECUTIVE BRANCH HISTORY
- History of the IOM Study
- The IOM Committee
- FORMULARIES AND FORMULARY SYSTEMS: HISTORY AND DEFINITIONS
- Modern Formularies and Formulary Systems
- Economic Focus of Formularies
- Types of Formularies and Their Restrictiveness
- Formulary Control
- GENERIC SUBSTITUTION
- THERAPEUTIC INTERCHANGE
- LOCAL VA FACILITY AND VISN FORMULARIES AND THE NATIONAL FORMULARY
- History of VA Formulary Management Prior to the National Formulary
- Reorganization of the VA
- Impact of the VA Fixed Budget
- Establishing the VA National Formulary
- Evolution of the National Formulary
- Medical Staff Input
- National Formulary Classes
- Formulary Relationship to Pharmaceutical Companies
- REPORT OUTLINE
- 2 Is the VA National Formulary Overly Restrictive and Does It Prevent Physicians from Meeting the Health Care Needs of…
- BACKGROUND
- Elements of Restrictiveness
- SIZE AND COVERAGE OF THE NATIONAL FORMULARY
- Adequacy of the VA National Formulary
- Closed and Preferred Drug Classes in the VA
- Restrictiveness of Class Closure
- Excluded Drugs and Other Limits
- National Formulary Effects on Drug Use
- ADDITION OF NEW DRUGS AND FORMULARY REAPPRAISAL
- National Policy Regarding New Drugs
- VISN Addition of New FDA Approvals
- Evaluation of the VA Process for Adding New FDA-Approved Priority Drugs
- Addition of Existing Drugs by the VA
- Addition of Newly Approved or Existing Drugs in Other Health Care Systems
- THE NONFORMULARY PROCESS
- THERAPEUTIC INTERCHANGE
- OTC DRUG COVERAGE, GENERIC SUBSTITUTION, AND PHYSICIAN SATISFACTION.
- Generic Substitution
- Veterans' Complaints
- VA Physician Satisfaction
- SUMMARY
- 3 What Are the Potential Costs to VA Health Care Associated with the National Formulary for Drugs?
- INTRODUCTION
- THE VHA NATIONAL FORMULARY AS IT AFFECTS COSTS
- Background
- Basic Economics of the VA National Formulary
- Features of the National Formulary
- VISN Implementation Issues
- Other Influences on VHA Pharmaceutical Spending
- ANALYTICAL FRAMEWORK
- DATA
- EMPIRICAL METHODS
- RESULTS OF THE IOM COMMITTEE ANALYSIS OF COST EFFECTS
- How Have the VHA and the Veteran User Population Changed During the Study Period?
- How Has the National Formulary Affected Prices for Closed and Preferred Classes?
- How Has the National Formulary Affected Prescribing Patterns Within the Closed and Preferred Classes?
- How Has the National Formulary Affected Pharmaceutical Spending per Veteran User for Closed and Preferred Classes?
- IS THERE EVIDENCE THAT CHANGES IN FORMULARY POLICY HAVE RESULTED IN INCREASED UTILIZATION ELSEWHERE IN THE VHA SYSTEM?
- Exploration of Changes in Hospital Discharges per VHA User
- COSTS ASSOCIATED WITH IMPLEMENTING AND MANAGING THE NATIONAL FORMULARY
- Estimated National Formulary Savings
- CONCLUSIONS
- 4 What Are the Effects of the National Formulary and Related Policies on Quality of Care?
- BACKGROUND INFORMATION
- Sources of Quality Data
- QUALITY OF CARE IN THE VHA AND EFFECTS OF THE NATIONAL FORMULARY
- PHARMACY, CLINICAL, AND FORMULARY PROGRAM ELEMENTS RELEVANT TO QUALITY OF CARE
- Clinical Pharmacy
- P&
- T COMMITTEES
- THE VA PBM COMPLEX
- Additions to, and Quality of, the National Formulary
- POLICIES AND PROCEDURES
- Drug Class Reviews
- Clinical Guidelines and Drug Utilization Reviews
- The Nonformulary Process
- Therapeutic Interchange, Policy, and Results.
- EFFECTS OF THE NATIONAL FORMULARY ON USE OF DRUGS BY THE VA
- ADVERSE DRUG EVENTS
- Changes in Inpatient Hospital Discharges Associated with the National Formulary
- PATIENT COMPLAINTS-ADVOCATE, VETERANS OF FOREIGN WARS, AND SURVEY DATA
- PHYSICIAN COMPLAINTS AND SURVEY DATA
- SUMMARY STATEMENT
- 5 How Does the VA National Formulary Compare with Private Insurance Formularies for Drugs and Devices and with Other…
- INTRODUCTION
- IMPLEMENTATION OF DRUG MANAGEMENT STRATEGIES IN MANAGED CARE
- IMPACT OF STATE LEGISLATION ON MCO PRACTICE
- PUBLIC-SECTOR PROGRAMS
- Medicaid
- Medicaid Fee for Service
- Medicaid Prescription Drug Benefit
- Medicaid Controls Prior Approval and Formulary Systems
- Comparison to the VA
- Effects of Medicaid Formularies and Formulary Systems
- Effects of Medicaid Prior Approval Systems
- Effects of Medicaid Prescription Limits
- Medicaid Managed Care: Background
- Drug Benefit in Medicaid Managed Care
- DEPARTMENT OF DEFENSE
- Health Care System and Pharmacy Benefit
- DOD Formulary and Formulary System
- GENERAL COMMENTS ON COMPARISONS
- 6 The VA National Formulary and Veterans Health Care
- INTRODUCTION
- BACKGROUND AND CONTEXT
- THE VETERANS HEALTH ADMINISTRATION
- RESTRICTIVENESS
- COSTS
- QUALITY
- COMPARISONS
- References
- Acronyms
- APPENDIX A Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the…
- JANUARY 28, 2000
- APPENDIX B Academy of Managed Care Pharmacy's Managed Care Formulary and Pharmacy Benefit Design Survey
- AMCP MANAGED CARE FORMULARY AND PHARMACY BENEFIT DESIGN SURVEY (JANUARY 2000)
- The P&
- T Committee
- Exclusion of Coverage
- Closed Formularies
- Open-Preferred Formularies
- Open-Passive Formularies
- Other Types of Formularies
- Drug Restrictions
- Generic Drugs.
- Access to Nonformulary Drugs
- Cost-Containment Measures
- Addition of New FDA-Approved Drugs
- Appeals Process
- Continuation of Care
- APPENDIX C Additional Cost Information
- APPENDIX D Glossary
- APPENDIX E Drug Classes and Drug Index
- DRUG CLASSES
- OTHER DRUGS
- Committee Biographies.
